Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Cytokinetics, Incorporated (CYTK) had Free Cash Flow of $-269.66M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$66.77M |
|
$-134.37M |
|
-- |
|
$66.77M |
|
$178.28M |
|
$-111.51M |
|
$-22.86M |
|
$-134.37M |
|
$-134.37M |
|
$-134.37M |
|
$-134.37M |
|
$-134.37M |
|
$-134.37M |
|
$-111.51M |
|
$-109.22M |
|
119.46M |
|
119.46M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$886.54M |
|
$70.22M |
|
$339.09M |
|
$1.23B |
|
$131.06M |
|
$713.04M |
|
$1.46B |
|
$1.59B |
|
$-368.72M |
|
$-368.72M |
|
$-368.72M |
|
119.60M |
|
| Cash Flow Statement Financials | |
$-259.85M |
|
$158.84M |
|
$83.29M |
|
$95.23M |
|
$76.55M |
|
$-18.68M |
|
$51.08M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.76 |
|
-- |
|
-- |
|
2.07 |
|
-1.97 |
|
100.00% |
|
-167.00% |
|
-167.00% |
|
-- |
|
-201.25% |
|
-201.25% |
|
|
Free Cash Flow |
$-269.66M |
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
7.94 |
|
11.34 |
|
36.44% |
|
36.44% |
|
-10.96% |
|
-39.02% |
|
$-3.08 |
|
$-2.26 |
|
$-2.18 |
|